These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19728317)

  • 1. Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease.
    Higuchi M; Hatta K; Honma T; Hitomi YH; Kambayashi Y; Hibino Y; Matsuzaki I; Sasahara S; Nakamura H
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):604-11. PubMed ID: 19728317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased systemic inflammatory interleukin-1ß and interleukin-6 during agitation as predictors of Alzheimer's disease.
    Honma T; Hatta K; Hitomi Y; Kambayashi Y; Hibino Y; Konoshita T; Nakamura H
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):233-41. PubMed ID: 22535710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
    Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
    Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
    Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agitated behaviours among the institutionalized elderly with dementia: validation of the Korean version of the Cohen-Mansfield Agitation Inventory.
    Suh GH
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):378-85. PubMed ID: 15065232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of soluble intercellular adhesion molecules in neurodegenerative disorders.
    Rentzos M; Michalopoulou M; Nikolaou C; Cambouri C; Rombos A; Dimitrakopoulos A; Vassilopoulos D
    J Neurol Sci; 2005 Feb; 228(2):129-35. PubMed ID: 15694193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.
    Zuliani G; Guerra G; Ranzini M; Rossi L; Munari MR; Zurlo A; Blè A; Volpato S; Atti AR; Fellin R
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):305-11. PubMed ID: 17022108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.
    Harper DG; Stopa EG; McKee AC; Satlin A; Fish D; Volicer L
    Neurobiol Aging; 2004 Jul; 25(6):771-81. PubMed ID: 15165702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of natural killer cells in Alzheimer's disease.
    Jadidi-Niaragh F; Shegarfi H; Naddafi F; Mirshafiey A
    Scand J Immunol; 2012 Nov; 76(5):451-6. PubMed ID: 22889057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder.
    Pike JL; Irwin MR
    Brain Behav Immun; 2006 Mar; 20(2):169-74. PubMed ID: 16023828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.
    Skjerve A; Holsten F; Aarsland D; Bjorvatn B; Nygaard HA; Johansen IM
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):343-7. PubMed ID: 15298644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study.
    Engelborghs S; Maertens K; Nagels G; Vloeberghs E; Mariën P; Symons A; Ketels V; Estercam S; Somers N; De Deyn PP
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1028-37. PubMed ID: 16250064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agitation and postdexamethasone cortisol levels in Alzheimer's disease.
    Lawlor BA; Tsuboyama G; Ryan T; Mohs RC; Davis BM; Davidson M; Gabriel S; Davis KL
    Am J Psychiatry; 1992 Apr; 149(4):546-8. PubMed ID: 1554044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling sundowning in a patient with Alzheimer's disease.
    Sharer J
    Medsurg Nurs; 2008 Feb; 17(1):27-9. PubMed ID: 18429537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Managing Alzheimer's disease. 5/6--agitation and aggression].
    Becue M
    Soins Gerontol; 2003; (42):38-9. PubMed ID: 12929535
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of therapeutic touch on behavioral symptoms and cortisol in persons with dementia.
    Woods DL; Beck C; Sinha K
    Forsch Komplementmed; 2009 Jun; 16(3):181-9. PubMed ID: 19657203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.